FOXQ1 and bladder transitional cell carcinoma: Compared with the III + IV stage, the FOXQ1 expression level in the I + II stage was higher in bladder urothelial carcinoma and skin cutaneous melanoma and lower in rectum adenocarcinoma, thyroid carcinoma, and testicular germ cell tumors (Figure 6B).